Abstract
The aim of this study was to investigate the relationship between hepatotoxicity, levels of glucuronide conjugates of valproic acid (VPA), and the toxic metabolites of VPA (4-ene VPA and 2,4-diene VPA). We also examined whether hepatotoxicity could be predicted by the urinary excretion levels of VPA and its toxic metabolites. VPA was administrated orally in rats in amounts ranging from 20 mg/kg to 500 mg/kg. Free and total (free plus glucuronide conjugated) VPA, 4-ene VPA, and 2,4-diene VPA were quantified in urine and liver using gas chromatography-mass spectrometry. Serum levels of aspartate aminotransferase, alanine aminotransferase, and α-glutathione S-transferase (α-GST) were also determined to measure the level of hepatotoxicity. The serum α-GST level increased slightly at the 20 mg/kg dose, and substantially increased at the 100 and 500 mg/kg dose; aspartate aminotransferase and alanine aminotransferase levels did not change with the administration of increasing doses of VPA. The liver concentration of free 4-ene VPA and the urinary excretion of total 4-ene VPA were the only measures that correlated with the increase in the serum α-GST level (p < 0.094 and p < 0.023 respectively). From these results, we conclude that hepatotoxicity of VPA correlates with liver concentration of 4-ene VPA and can be predicted by the urinary excretion of total 4-ene VPA.
Similar content being viewed by others
References
Beckett, G. J. and Hayes, J. D., Glutathione S-transferases: biomedical applications. Adv. Clin. Chem., 30, 281–380 (1993).
Bryant, A. E. and Dreifuss, F. E., Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology, 46, 465–469 (1996).
Dickinson, R. G., Harland, R. C., Ilias, A. M., Rodgers, R. N., Kaufman, S. N., Lynn, R. K., and Gerber, N., Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. J. Pharmacol. Exp. Ther., 11, 583–595 (1979).
Dickinson, R. G., Hooper, W. D., Dunstan, P. R., and Eadic, M. J., Urinary excretion of valproate and some metabolites in chronically treated patients. Ther. Drug Monit., 11, 127–133 (1989).
Gopaul, S. V., Mutlib, A., and Farrell, K., Identification and characterization of N-acetylcystein conjugates of valproic acid in patients on valproic acid therapy. Drug Metab. Dispos., 28, 823–832 (2000).
Granneman, G. R., Wang, S. I., Kesterson, J. W., and Machihist, J. M., The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology, 4, 1153–8 (1984a).
Granneman, G. R., Wang, S. I., Machinist, J. M., and Kesterson, J. W., Aspects of the metabolism of valproic acid. Xenobiotica, 14, 375–387 (1984b).
Hergüner, M. O., Altunbaþak, S., Dogan, A., Yildizdas, D., Incecik, F., Erdogan, S., Gönlüsen, G., Daglioglu, K., Dikmen, N., and Burgut, R., Effects of sodium valproate on renal functions in rats. Ren. Fail., 28, 593–597 (2006)
Kassahun, K., Farrell, K., and Abbott, F. S., Identification and characterization of the glutathione and N-acetyl conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid in rats and humans. Drug Metab. Dispos., 19, 525–535 (1991).
Korkmazer, N., Vurucu, S., Demirkaya, E., Unay, B., Kul, M., Akin, R., and Gokcay, E., Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev., 28, 515–20 (2006)
Koo, D. J., Zhou, M., Claudry, I. H., and Wang, P., Plasma α-glutathione S-transferase, A sensitive Indicator of hepatocellular damage during polymicrobial sepsis, Arch. Surg., 135, 198–203 (2000).
Loguercio, C., Tuccillo, C., Caporaso, N., Del Vecchio Blanco, G., Morisco, F., Guerriero, C., Di Santolo, S. S., Valenza, L. M., and Del Vecchio Blanco, C., Determination of plasma alpha-glutathione S-transferases in patients with HCV-related chronic infection: its significance and possible clinical relevance. Liver, 18, 166–172 (1998).
Loscher, W., Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol., 58, 31–59 (1999).
Murakami, K., Sugimoto, T., Nishida, N., Kobayashi, Y., Kuhara, T., and Matsumoto, I., Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy. Brain Dev., 14, 178–181 (1992).
Nau, H. and Wittfoht, W., Valproic acid and several metabolites: Quantitative determination in serum urine, breast milk and tissues by gas chromatography-mass spectrometry using selected ion monitoring. J. Chromatogr., 226, 69–78 (1981).
Perucca, E., Pharmacological and therapeutic properties of valproate. A summary after 35 years of clinical experience. CNS Drugs, 16, 695–714 (2002).
Ray, D. C., Robbins, A. G., Howie, A. F., and Beckett, G. J., Drummond, G. B., Effect of spinal anaesthesia on plasma concentrations of glutathione S-transferase. Br. J. Anaesth., 88, 285–287 (2002).
Rettenmeier, A. W., Gordon, W. P., Prickett, K. S., Levy, R. H., and Baillie, T. A., Biotransformation and pharmacokinetic in the rhesus monkey of 2-n-propyl-4-pentanoic acid, a toxic metabolite of valproic acid. Drug Metab. Dispos. 14, 454–464 (1986).
Rettenmeier, A. W., Prickett, K. S., Gordon, W. P., Bjorge, S. M., Chang, S. L., Levy, R. H., and Baillie, T. A., Studies on the biotransformation in the perfused rat liver of 2-npropyl-4-pentanoic acid, a metabolite of antiepileptic drug valproic acid. Drug Metab. Dispos., 13, 81–96 (1985).
Seimes, H., Nau, H., and Schultz, K., Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia, 34, 332–346 (1993).
Sugimoto, T., Nishida, N., Yasuhara, A., Ono, A., Sakane, Y., and Matsumura, T., Reye-like syndrome associated with valproic acid. Brain Dev., 5, 334–337 (1983).
Tong, V., Teng, X. W., Chang, T. K., and Abott, F. S., Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione depleted rat hepatocytes. Toxicol. Sci., 86, 436–443 (2005).
Wang, P., Ba, Z. F., Tait, S. M., Zhou, M., Chaudry, I. H., Alterations in circulation blood volume during poly-microbial sepsis. Circ. Shock, 40, 92–98 (1993).
Yu, H. Y. and Shin, M. C., Determination of valproic acid in human plasma by capillary gas chromatography. Therp. Drug Monit., 18, 107–108 (1996).
Zafrani, E. S. and Berthelot, P., Sodium valproate in the induction of unusual hepatotoxicity. Hepatology, 2, 648–649 (1982).
Zimmerman, H. J. and Ishak, K. G., Valproate-induced hepatic injury: Analysis of 23 fatal cases. Hepatology, 2, 591–597 (1982).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, M.S., Lee, YJ., Kim, B.J. et al. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid. Arch. Pharm. Res. 32, 1029–1035 (2009). https://doi.org/10.1007/s12272-009-1708-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1708-x